chlorthalidone has been researched along with Premenstrual Syndrome in 2 studies
Chlorthalidone: A benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic.
Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mattsson, B | 1 |
| von Schoultz, B | 1 |
| Graudenz, MG | 1 |
1 trial available for chlorthalidone and Premenstrual Syndrome
| Article | Year |
|---|---|
A comparison between lithium, placebo and a diuretic in premenstrual tension.
Topics: Chlorthalidone; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Lithium; Placebos; Premen | 1974 |
1 other study available for chlorthalidone and Premenstrual Syndrome
| Article | Year |
|---|---|
[Use of chlorthalidone in patients using oral contraceptives].
Topics: Adult; Body Weight; Chlorthalidone; Contraceptives, Oral; Edema; Epilepsy; Female; Headache; Humans; | 1969 |